Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cells for Lung Injury from Infectious Diseases
NCT06416709Phase 2Recruiting
- Sponsor
- Cell Energy Life Science
- Start
- May 2023
- Primary completion
- May 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in not applicable; "lung injury" is not a specific disease, sponsored by Cell Energy Life Science. Started May 2023; status: recruiting.
02
Drugs
mesenchymal stem cells
03
Conditions
not applicable; "lung injury" is not a specific disease
Beyond the preview
Go deeper on NCT06416709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06416709.